Unclear ownership
Teams understand individual tasks, but accountability for handoffs, decisions, and closure is uncertain.
Find the friction. Clarify the priorities. Define a practical path forward.
As biotech organizations grow, spreadsheets, email, shared repositories, manual follow-up, and disconnected systems can make ownership, status, decisions, and supporting evidence increasingly difficult to manage. This focused assessment identifies where fragmented work and disconnected information are creating operational risk or unnecessary effort—and establishes practical priorities for improvement.
Discuss the diagnosticWHEN TO CONSIDER IT
Teams understand individual tasks, but accountability for handoffs, decisions, and closure is uncertain.
Dates, decisions, risks, and progress differ across spreadsheets, messages, repositories, or systems.
People repeatedly compare sources, recreate context, and prepare reports to understand the current state.
Records, documents, decisions, tasks, and supporting information are difficult to follow as one story.
Leaders receive summaries without a reliable path to the underlying work, ownership, and evidence.
The organization is considering a new system, migration, or AI capability before requirements and priorities are fully understood.
WHAT WE EXAMINE
HOW IT WORKS
The engagement concentrates on agreed areas of R&D operations and representative, nonconfidential operating materials.
Confirm objectives, scope, participants, and representative materials.
Interview stakeholders and examine selected workflows, handoffs, information, and tools.
Identify friction, risks, dependencies, data concerns, and improvement opportunities.
Separate immediate improvements from longer-term process and technology needs.
Present findings and a practical, sequenced roadmap for action.
WHAT YOU RECEIVE
A concise view of the selected workflows, responsibilities, information flows, tools, and dependencies.
Documented operational risks, coordination gaps, data-quality observations, and improvement opportunities.
Practical actions that can reduce friction without waiting for a major technology program.
Sequenced priorities, suggested ownership, dependencies, and next decisions.
A facilitated review of observations, implications, priorities, and possible next steps.
ENGAGEMENT AT A GLANCE
Focused advisory scope: The R&D Operations Diagnostic is not an audit, formal validation, regulatory determination, or exhaustive enterprise assessment. It is offered as a focused, fixed-scope engagement. Final scope, duration, and pricing are confirmed after an introductory conversation.
START WITH A FOCUSED CONVERSATION
Tell us about the workflow, operational challenge, or upcoming decision you would like to examine.